Dr. Amy Caudy, PhD

Assistant Professor, Terrence Donnelly Centre for Cellular and Biomolecular Research and the Dept of Molecular Genetics

Amy Caudy graduated summa cum laude with a degree in biochemistry from Washington University in St. Louis, working with Craig Pikaard on RNA polymerase I transcription. She earned her PhD from the Watson School of Biological Sciences at Cold Spring Harbor Laboratory, working with Gregory Hannon identifying protein components of the RNAi complex RISC. Amy then joined John Atkinson’s laboratory at Washington University School of Medicine to T regulatory cells as a Ruth Kirchstein NRSA Postdoctoral Fellow. In 2005, she became a Lewis-Sigler Fellow at the Lewis-Sigler Institute for Integrative Genomics at Princeton University. There, she turned to the study of metabolism. As an assistant professor at the University of Toronto, the focus of her laboratory is the discovery of novel metabolic pathways; one recent success has been the discovery of a new pathway for the production of ribose. Her work along the way has included the development of genome- scale methods for experiments in yeast and other organisms. Along with James Watson, Amy is an author of the textbook, Recombinant DNA: Genes and Genomes.

Dr. Trevor Moraes, PhD

Assistant Professor in the Dept of Biochemistry at the University of Toronto

Dr. Moraes has been an Assistant Professor in the Department of Biochemistry since 2009 and was recently awarded a Tier II Canada Research Chair in the Structural Biology of Membrane Proteins. He completed is undergraduate training in the Department of Biochemistry at Queen’s University in 1997 and an MSc there with Dr. William Plaxton in 1999. He obtained his PhD in 2004 at the University of Alberta, supervised by Drs. Michael Ellison and J.N.Mark Glover, followed by post-doctoral studies with Dr. Natalie Strynadka at the University of British Columbia

Dr. James Woodgett, PhD

Director of Research at the Samuel Lunenfeld Research Institute

Jim Woodgett has worked at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital since 2005 and was previously Head, Division of Experimental Therapeutics at the Ontario Cancer Institute. His laboratory studies signal transduction in normal development and diseases (especially protein kinases), has published over 240 papers and he is actively involved in science policy. Although he worries about his trainees, he is confident they’ll change the world.